companydata.dkcompanydata.dk

SSI Diagnostica A/S: Financial statements 2019

CVR: 37294535

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

SSI Diagnostica A/S (CVR 37294535) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 103,740,492 and a net result of DKK 24,369,283 compared with DKK 19,359,946 the year before. That is an increase of 8.9% compared with the year before. Equity in the 2019 report amounted to DKK 97,111,716. The solvency ratio was 33.5%.

Gross Profit
DKK 103,740,492
Profit/Loss
DKK 24,369,283
Equity
DKK 97,111,716
Total Assets
DKK 290,318,924

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-103.7M24.4M97.1M-
2018-95.3M19.4M83.2M-
2017-93.3M18.5M63.8M-
2016-33.2M12M45.3M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

SSI Diagnostica A/S: The 2018 annual report is outMay 6, 2019

SSI Diagnostica A/S has published its annual report for 2018. Gross profit came to DKK 95,295,817, and the net result was DKK 19,359,946.

About SSI Diagnostica A/S

SSI Diagnostica A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Christina Charlotte Lindved and Lars Henrik Vejrup Hansen. The board consists of Nachum Shamir (chair), Ingo Sujit Michael Chakravarty, Joseph Edward Bernardo and Patrik Olof Dahlén. The company is owned by SSI Diagnostica Holding A/S. The company has 151 employees (2026). In 2025, the company reported revenue of DKK 320,248,428 and a net result of DKK -107,420,232 compared with DKK -57,738,206 the year before. Equity in the 2025 report amounted to DKK 695,791,068.

Source: annual report 2025, Danish Business Authority